A genetic model for colorectal tumorigenesis

Genetic Alterations during Colorectal-Tumor Development

Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471

ras GENES

Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885

Mutations in the p53 gene occur in diverse human tumour types

Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K. R., Signer, S. H., Davidson, N. E., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,730

Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas

Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,097

The p53 proto-oncogene can act as a suppressor of transformation

Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., & White, R. L. (1983) · Nature · doi:10.1038/305779a0 · Cited by 1,919

Prevalence of ras gene mutations in human colorectal cancers

Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., BOOM, J. H. V., van der Eb, A. J., & Vogelstein, B. (1987) · Nature · doi:10.1038/327293a0 · Cited by 1,860

Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers

Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,760

The Molecular Genetics of Cancer

Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,674

KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer

Burgess, M. R., Hwang, E., Mroue, R., Bielski, C. M., Wandler, A. M., Huang, B. J., Firestone, A. J., Young, A., Lacap, J. A., Crocker, L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.01.020 · Cited by 183

Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia

Baek, S. J., Okazaki, R., Lee, S.-H., Martinez, J., Kim, J.-S., Yamaguchi, K., Mishina, Y., Martin, D. W., Shoieb, A., Mcentee, M. F., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.015 · Cited by 175

α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer

Tran, T. Q., Hanse, E. A., Habowski, A. N., Li, H., Ishak Gabra, M. B., Yang, Y., Lowman, X. H., Ooi, A. M., Liao, S. Y., Edwards, R. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0035-5 · Cited by 161

Physical Activity and Cancer Prevention: Pathways and Targets for Intervention

Rogers, C. J., Colbert, L. H., Greiner, J. W., Perkins, S. N., & Hursting, S. D. (2008) · Sports Medicine · doi:10.2165/00007256-200838040-00002 · Cited by 170

PTP1B Contributes to the Oncogenic Properties of Colon Cancer Cells through Src Activation

Zhu, S., Bjorge, J. D., & Fujita, D. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4338 · Cited by 168

Role of Mutagenicity in Asbestos Fiber-Induced Carcinogenicity and Other Diseases

Huang, S. X. L., Jaurand, M.-C., Kamp, D. W., Whysner, J., & Hei, T. K. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.556051 · Cited by 163

TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype

Fessler, E., Drost, J., van Hooff, S. R., Linnekamp, J. F., Wang, X., Jansen, M., De Sousa E Melo, F., Prasetyanti, P. R., IJspeert, J. E., Franitza, M., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606184 · Cited by 159

A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer

Liao, H., Li, X., Zhao, L., Wang, Y., Wang, X., Wu, Y., Zhou, X., Fu, W., Liu, L., Hu, H.-G., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-0171-1 · Cited by 156

RAS signaling pathways, mutations and their role in colorectal cancer

Zenonos, K. (2013) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v5.i5.97 · Cited by 156

Mechanisms of Resistance to KRASG12C-Targeted Therapy

Akhave, N. S., Biter, A. B., & Hong, D. S. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1616 · Cited by 156

Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment

Khoo, B. L., Grenci, G., Jing, T., Lim, Y. B., Lee, S. C., Thiery, J. P., Han, J., & Lim, C. T. (2016) · Science Advances · doi:10.1126/sciadv.1600274 · Cited by 147

Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids

Pongracz, J., Clark, P., Neoptolemos, J. P., & Lord, J. M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610107 · Cited by 137

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab

Dunn, E. F., Iida, M., Myers, R. A., Campbell, D. A., Hintz, K. A., Armstrong, E. A., Li, C., & Wheeler, D. L. (2011) · Oncogene · doi:10.1038/onc.2010.430 · Cited by 133

Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.

Cartwright, C. A., Coad, C. A., & Egbert, B. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117000 · Cited by 134

Increased colon cancer risk after severe Salmonella infection

Mughini-Gras, L., Schaapveld, M., Kramers, J., Mooij, S., Neefjes-Borst, E. A., Pelt, W. V., & Neefjes, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189721 · Cited by 133

Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity

Jansen, A. P., Camalier, C. E., Stark, C., & Colburn, N. H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.103.3.2 · Cited by 132

Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies

Mina, M., Raynaud, F., Tavernari, D., Battistello, E., Sungalee, S., Saghafinia, S., Laessle, T., Sanchez-Vega, F., Schultz, N., Oricchio, E., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.010 · Cited by 129

The role of the PI3K pathway in colorectal cancer

Papadatos-Pastos, D., Rabbie, R., Ross, P., & Sarker, D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.12.006 · Cited by 126

Precancerous neoplastic cells can move through the pancreatic ductal system

Makohon-Moore, A. P., Matsukuma, K., Zhang, M., Reiter, J. G., Gerold, J. M., Jiao, Y., Sikkema, L., Attiyeh, M. A., Yachida, S., Sandone, C., et al. (2018) · Nature · doi:10.1038/s41586-018-0481-8 · Cited by 120

Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy

Drewes, J. L., Housseau, F., & Sears, C. L. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.189 · Cited by 121

Fusion genes and chromosome translocations in the common epithelial cancers

Edwards, P. A. (2010) · The Journal of Pathology · doi:10.1002/path.2632 · Cited by 126

Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma

Heinmöller, E., Dietmaier, W., Zirngibl, H., Heinmöller, P., Scaringe, W., Jauch, K.-W., Hofstädter, F., & Rüschoff, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64520-8 · Cited by 121

Cancer research using organoid technology

Kretzschmar, K. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01990-z · Cited by 120

Oncogenic mutations as predictive factors in colorectal cancer

Lièvre, A., Blons, H., & Laurent-Puig, P. (2010) · Oncogene · doi:10.1038/onc.2010.89 · Cited by 117

Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology–molecular associations: clinical and biological implications

Shia, J., Schultz, N., Kuk, D., Vakiani, E., Middha, S., Segal, N. H., Hechtman, J. F., Berger, M. F., Stadler, Z. K., Weiser, M. R., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.198 · Cited by 105

HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy

Anderson, P., Aptsiauri, N., Ruiz-Cabello, F., & Garrido, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00634-7 · Cited by 107

Integrating the DNA damage and protein stress responses during cancer development and treatment

Gorgoulis, V. G., Pefani, D., Pateras, I. S., & Trougakos, I. P. (2018) · The Journal of Pathology · doi:10.1002/path.5097 · Cited by 108

MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer

Cipponi, A., Goode, D. L., Bedo, J., McCabe, M. J., Pajic, M., Croucher, D. R., Rajal, A. G., Junankar, S. R., Saunders, D. N., Lobachevsky, P., et al. (2020) · Science · doi:10.1126/science.aau8768 · Cited by 103

MicroRNA-520g Confers Drug Resistance by Regulating p21 Expression in Colorectal Cancer

Zhang, Y., Geng, L., Talmon, G., & Wang, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.620252 · Cited by 100

MicroRNA-224 sustains Wnt/β-catenin signaling and promotes aggressive phenotype of colorectal cancer

Li, T., Lai, Q., Wang, S., Cai, J., Xiao, Z., Deng, D., He, L., Jiao, H., Ye, Y., Liang, L., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0287-1 · Cited by 92

Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA

Huang, Y., Liu, N., Liu, J., Liu, Y., Zhang, C., Long, S., Luo, G., Zhang, L., & Zhang, Y. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1688951 · Cited by 94

Effect of Ursodeoxycholic Acid Use on the Risk of Colorectal Neoplasia in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Singh, S., Khanna, S., Pardi, D. S., Loftus, E. V., & Talwalkar, J. A. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318286fa61 · Cited by 94

Human embryonic stem cells: Long term stability, absence of senescence and a potential cell source for neural replacement

Zeng, X., & Rao, M. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.017 · Cited by 92

Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: A review

Baas, J. M., Krens, L. L., Guchelaar, H.-J., Morreau, H., & Gelderblom, H. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0024 · Cited by 89

Selective targeting of mutant adenomatous polyposis coli ( APC ) in colorectal cancer

Zhang, L., Theodoropoulos, P. C., Eskiocak, U., Wang, W., Moon, Y.-A., Posner, B., Williams, N. S., Wright, W. E., Kim, S. B., Nijhawan, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf8127 · Cited by 88

Genotoxicity of Cytolethal Distending Toxin (CDT) on Isogenic Human Colorectal Cell Lines: Potential Promoting Effects for Colorectal Carcinogenesis

Graillot, V., Dormoy, I., Dupuy, J., Shay, J. W., Huc, L., Mirey, G., & Vignard, J. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00034 · Cited by 87

Consensus molecular subtype classification of colorectal adenomas

Komor, M. A., Bosch, L. J., Bounova, G., Bolijn, A. S., Delis‐van Diemen, P. M., Rausch, C., Hoogstrate, Y., Stubbs, A. P., de Jong, M., Jenster, G., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5129 · Cited by 86

Extracting Intercellular Signaling Network of Cancer Tissues using Ligand-Receptor Expression Patterns from Whole-tumor and Single-cell Transcriptomes

Zhou, J. X., Taramelli, R., Pedrini, E., Knijnenburg, T., & Huang, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-09307-w · Cited by 85

Identification of genes involved in epithelial-mesenchymal transition and tumor progression

Kiemer, A. K., Takeuchi, K., & Quinlan, M. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204872 · Cited by 77

Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment

Gmeiner, W. H. (2024) · Cancers · doi:10.3390/cancers16051029 · Cited by 78

Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer

Kloth, M., Ruesseler, V., Engel, C., Koenig, K., Peifer, M., Mariotti, E., Kuenstlinger, H., Florin, A., Rommerscheidt-Fuss, U., Koitzsch, U., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-309026 · Cited by 73

Genetic toxicology data in the evaluation of potential human environmental carcinogens

Waters, M. D., Stack, H. F., & Jackson, M. A. (1999) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(99)00037-x · Cited by 73

Dependence Receptors and Cancer: Addiction to Trophic Ligands

Gibert, B., & Mehlen, P. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3652 · Cited by 73

American Association of Clinical Endocrinologists Medical Guidelines for the Clinical Use of Dietary Supplements and Nutraceuticals

Mechanick, J. I., Brett, E. M., Chausmer, A. B., Dickey, R. A., Wallach, S., Bergman, D. A., Garber, J. R., Hamilton, C. R., Handelsman, Y., Holdy, K. E., et al. (2003) · Endocrine Practice · doi:10.4158/ep.9.5.417 · Cited by 73

Contribution of pks+ E. coli mutations to colorectal carcinogenesis

Chen, B., Ramazzotti, D., Heide, T., Spiteri, I., Fernandez-Mateos, J., James, C., Magnani, L., Graham, T. A., & Sottoriva, A. (2023) · Nature Communications · doi:10.1038/s41467-023-43329-5 · Cited by 74

Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions

Bachor, C., Bachor, O. A., & Boukamp, P. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050302 · Cited by 68

Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer

Seth, R., Crook, S., Ibrahem, S., Fadhil, W., Jackson, D., & Ilyas, M. (2009) · Gut · doi:10.1136/gut.2008.159137 · Cited by 66

One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids

Geurts, M. H., Gandhi, S., Boretto, M. G., Akkerman, N., Derks, L. L. M., van Son, G., Celotti, M., Harshuk-Shabso, S., Peci, F., Begthel, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40701-3 · Cited by 66

Expression of Jun family members in human colorectal adenocarcinoma

Wang, H., Birkenbach, M., & Hart, J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.7.1313 · Cited by 64

ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells

Sen, M., Wang, X., Hamdan, F. H., Rapp, J., Eggert, J., Kosinsky, R. L., Wegwitz, F., Kutschat, A. P., Younesi, F. S., Gaedcke, J., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0690-5 · Cited by 61

Elucidating the interactions between the adhesive and transcriptional functions of -catenin in normal and cancerous cells

van Leeuwen, I. M. M., Byrne, H. M., Jensen, O. E., & King, J. R. (2007) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2007.01.019 · Cited by 59

Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology

László, L., Kurilla, A., Takács, T., Kudlik, G., Koprivanacz, K., Buday, L., & Vas, V. (2021) · Cells · doi:10.3390/cells10030667 · Cited by 58

Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications

Cao, Q., Tian, Y., Deng, Z., Yang, F., & Chen, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063358 · Cited by 60

Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers

Ku, J.-L., Shin, Y.-K., Kim, D.-W., Kim, K.-H., Choi, J.-S., Hong, S.-H., Jeon, Y.-K., Kim, S.-H., Kim, H.-S., Park, J.-H., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq043 · Cited by 52

Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells

Emaduddin, M., Bicknell, D. C., Bodmer, W. F., & Feller, S. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712176105 · Cited by 50

Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS -Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study

Ahn, D. H., Barzi, A., Ridinger, M., Samuëlsz, E., Subramanian, R. A., Wu, C.-C., Croucher, P. J. P., Smeal, T., Kabbinavar, F. F., & Lenz, H.-J. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3053 · Cited by 49

KRAS mutational status in Japanese patients with colorectal cancer: Results from a nationwide, multicenter, cross-sectional study

Watanabe, T., Yoshino, T., Uetake, H., Yamazaki, K., Ishiguro, M., Kurokawa, T., Saijo, N., Ohashi, Y., & Sugihara, K. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt062 · Cited by 46

Genetic Alterations of Metastatic Colorectal Cancer

Testa, U., Castelli, G., & Pelosi, E. (2020) · Biomedicines · doi:10.3390/biomedicines8100414 · Cited by 44

Screening and Surveillance of Colorectal Cancer: A Review of the Literature

Maida, M., Dahiya, D. S., Shah, Y. R., Tiwari, A., Gopakumar, H., Vohra, I., Khan, A., Jaber, F., Ramai, D., & Facciorusso, A. (2024) · Cancers · doi:10.3390/cancers16152746 · Cited by 43

The effect of unfiltered coffee on potential biomarkers for colonic cancer risk in healthy volunteers: a randomized trial

Grubben, Braak, V. D., Broekhuizen, Jong, D., Rijt, V., Ruijter, D., Peters, Katan, & Nagengast (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00826.x · Cited by 41

Radiation protection in space

Durante, M. (2002) · La Rivista del Nuovo Cimento · doi:10.1007/bf03548911 · Cited by 38

Colorectal Cancer Immunotherapy: State of the Art and Future Directions

Cornista, A. M., Giolito, M. V., Baker, K., Hazime, H., Dufait, I., Datta, J., Khumukcham, S. S., De Ridder, M., Roper, J., Abreu, M. T., et al. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.09.007 · Cited by 39

Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells

Sommer, C. A., Capilla, A., Molina-Estevez, F. J., Gianotti-Sommer, A., Skvir, N., Caballero, I., Chowdhury, S., & Mostoslavsky, G. (2018) · PLOS ONE · doi:10.1371/journal.pone.0200657 · Cited by 39

The Interactions of DNA Repair, Telomere Homeostasis, and p53 Mutational Status in Solid Cancers: Risk, Prognosis, and Prediction

Vodicka, P., Andera, L., Opattova, A., & Vodickova, L. (2021) · Cancers · doi:10.3390/cancers13030479 · Cited by 39

Usp22 deficiency impairs intestinal epithelial lineage specification in vivo

Kosinsky, R. L., Wegwitz, F., Hellbach, N., Dobbelstein, M., Mansouri, A., Vogel, T., Begus-Nahrmann, Y., & Johnsen, S. A. (2015) · Oncotarget · doi:10.18632/oncotarget.5412 · Cited by 34

CDDO-Me protects against space radiation-induced transformation of human colon epithelial cells

Eskiocak, U., Kim, S. B., Roig, A. I., Kitten, E., Batten, K., Cornelius, C., Zou, Y. S., Wright, W. E., & Shay, J. W. (2010) · Radiation Research · doi:10.1667/rr2155.1 · Cited by 36

Novel loss‐of‐function mutations of the haematopoiesis‐related transcription factor, acute myeloid leukaemia 1/runt‐related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome

Nakao, M., Horiike, S., Fukushima‐Nakase, Y., Nishimura, M., Fujita, Y., Taniwaki, M., & Okuda, T. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04966.x · Cited by 34

Engineering cell heterogeneity into organs-on-a-chip

Mertz, D. R., Ahmed, T., & Takayama, S. (2018) · Lab on a Chip · doi:10.1039/c8lc00413g · Cited by 33

Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches

Atreya, C. E., Yaeger, R., & Chu, E. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175679 · Cited by 35

LBP and CD14 polymorphisms correlate with increased colorectal carcinoma risk in Han Chinese

Chen, R. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i18.2326 · Cited by 31

Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis

Chang, S.-C., Lin, P.-C., Lin, J.-K., Lin, C.-H., Yang, S.-H., Liang, W.-Y., Chen, W.-S., & Jiang, J.-K. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4899-z · Cited by 31

Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis

Hou, Y.-C., Hu, Q., Huang, J., Fang, J.-Y., & Xiong, H. (2017) · Oncotarget · doi:10.18632/oncotarget.13633 · Cited by 29

PDCD4 Knockdown Induces Senescence in Hepatoma Cells by Up-Regulating the p21 Expression

Guo, J., Ozaki, I., Xia, J., Kuwashiro, T., Kojima, M., Takahashi, H., Ashida, K., Anzai, K., & Matsuhashi, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00661 · Cited by 29

CK1α overexpression correlates with poor survival in colorectal cancer

Richter, J., Kretz, A.-L., Lemke, J., Fauler, M., Werner, J.-U., Paschke, S., Leithäuser, F., Henne-Bruns, D., Hillenbrand, A., & Knippschild, U. (2018) · BMC Cancer · doi:10.1186/s12885-018-4019-0 · Cited by 28

Tumor interactions with soluble factors and the nervous system

Voss, M. J., & Entschladen, F. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-21 · Cited by 25

Adenoma detection rate in 41,010 patients from Southwest China

CAI, B., LIU, Z., XU, Y., WEI, W., & ZHANG, S. (2015) · Oncology Letters · doi:10.3892/ol.2015.3005 · Cited by 22

The Presence of Telomere Fusion in Sporadic Colon Cancer Independently of Disease Stage, TP53/KRAS Mutation Status, Mean Telomere Length, and Telomerase Activity

Tanaka, H., Beam, M. J., & Caruana, K. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.009 · Cited by 19

Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development

Gmeiner, W. H. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s242224 · Cited by 18

Telomere length in the colon is related to colorectal adenoma prevalence

Peacock, S. D., Massey, T. E., Vanner, S. J., & King, W. D. (2018) · PLOS ONE · doi:10.1371/journal.pone.0205697 · Cited by 14

Telomeres and telomerase in the clinical management of colorectal cancer

Piñol-Felis, C., Fernández-Marcelo, T., Viñas-Salas, J., & Valls-Bautista, C. (2017) · Clinical and Translational Oncology · doi:10.1007/s12094-016-1559-0 · Cited by 13

Wnt activation disturbs cell competition and causes diffuse invasion of transformed cells through NF-κB-MMP21 pathway

Nakai, K., Lin, H., Yamano, S., Tanaka, S., Kitamoto, S., Saitoh, H., Sakuma, K., Kurauchi, J., Akter, E., Konno, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42774-6 · Cited by 14

Structurally complex osteosarcoma genomes exhibit limited heterogeneity within individual tumors and across evolutionary time

Rajan, S., Zaccaria, S., Cannon, M. V., Cam, M., Gross, A. C., Raphael, B. J., & Roberts, R. D. (2021) · doi:10.1101/2021.08.30.458268 · Cited by 33

Consensus molecular subtype transition during progression of colorectal cancer

van de Weerd, S., Torang, A., Zwager, L. W., Koelink, P. J., Koster, J., Bastiaansen, B. A., Lammers, V., Longobardi, C., Roodhart, J. M., van Krieken, J. H., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6176 · Cited by 6

Aberrant protein glycosylation in the colon adenoma-cancer sequence: Colorectal cancer mechanisms and clinical implications.

Yingli, H., Ping, Y., Jun, Y., & Xingwang, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167853 · Cited by 7

Tumorigenesis and cell evolution

Cai, D. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90256-2

Progress of the relationship between aberrant p53 protein and tumorigenesis

Xu, J. (2019) · doi:10.3760/cma.j.issn.1006-9801.2019.09.014

Expression of PTTG and its significance in colorectal cancer

Wei-guang, M. (2008) · Shandong yiyao

Metastasis suppressors Nm23H1 and Nm23H2 differentially regulate neoplastic transformation and tumorigenesis

Tong, Y., Yung, L. Y., & Wong, Y. H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.050 · Cited by 20

Psychogenic carcinogenesis: Carcinogenesis is without exogenic carcinogens

Bukhtoyarov, O. V., & Самарин, Д. М. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.06.004 · Cited by 7